ELAPOR1 and breast carcinoma: Our analysis from publicly-available datasets, using the OncomineTM Platform (http://www.oncomine.com), shows EIG121 to be over-expressed in breast cancer compared to other cancer types (Additional file 1: Table S1; [8]) and compared to normal breast tissue (Additional file 2: Table S2; [9, 10]).